|
|
||||||||
The 83-kilodalton (kD) apical membrane antigen of Plasmodium falciparum (PF83/AMA-1) is a potential asexual blood stage vaccine component. This antigen has been expressed as a full-length, nonfusion, recombinant baculovirus protein (PF83-7G8-1) using the authentic predicted signal peptide for appropriate postsynthetic routing. When purified by a novel high-performance, ion exchange chromatography (HPIEC) method, PF83-7G8-1 induced polyclonal antibodies in rats that immunoprecipitated both 83- and 66-kD forms of PF83/AMA-1 from 35S-methionine metabolically labeled parasite extracts. Using HPIEC-purified PF83-7G8-1 in combinantion with a rat monoclonal antibody against the highly conserved carboxy-terminal (CT) region of PF83/AMA-1, we developed a CT-capture-enzyme-linked immunosorbent assay to measure naturally acquired responses against the entire PF83/AMA-1 molecule. Analysis of populations from villages in Guinea-Bissau and in an area of high malarial transmission in Senegal demonstrated a very high prevalence (94100%) of naturally acquired serum IgG responses to PF83/AMA-1. Analysis of these natural responses showed that PF83/AMA-1 may be a well-recognized asexual parasite antigen. A statistically significant age-related change in antibody levels to PF83/AMA-1 was observed in Guinea-Bissau. No such correlation was observed in the Senegalese population, although an age-related antibody response was seen for total parasite antigen. No significant correlation was observed between PF83/AMA-1 responses and the parameters of parasite load and malaria-related fever.
This article has been cited by other articles:
![]() |
E. J. Remarque, B. W. Faber, C. H. M. Kocken, and A. W. Thomas A Diversity-Covering Approach to Immunization with Plasmodium falciparum Apical Membrane Antigen 1 Induces Broader Allelic Recognition and Growth Inhibition Responses in Rabbits Infect. Immun., June 1, 2008; 76(6): 2660 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Faber, E. J. Remarque, W. D. Morgan, C. H. M. Kocken, A. A. Holder, and A. W. Thomas Malaria Vaccine-Related Benefits of a Single Protein Comprising Plasmodium falciparum Apical Membrane Antigen 1 Domains I and II Fused to a Modified Form of the 19-Kilodalton C-Terminal Fragment of Merozoite Surface Protein 1 Infect. Immun., December 1, 2007; 75(12): 5947 - 5955. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Pal-Bhowmick, M. Mehta, I. Coppens, S. Sharma, and G. K. Jarori Protective Properties and Surface Localization of Plasmodium falciparum Enolase Infect. Immun., November 1, 2007; 75(11): 5500 - 5508. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gunasekera, T. Wickramarachchi, D. E. Neafsey, I. Ganguli, L. Perera, P. H. Premaratne, D. Hartl, S. M. Handunnetti, P. V. Udagama-Randeniya, and D. F. Wirth Genetic Diversity and Selection at the Plasmodium vivax Apical Membrane Antigen-1 (PvAMA-1) Locus in a Sri Lankan Population Mol. Biol. Evol., April 1, 2007; 24(4): 939 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. MORAIS, I. S. SOARES, L. H. CARVALHO, C. J. F. FONTES, A. U. KRETTLI, and E. M. BRAGA ANTIBODIES TO PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1: PERSISTENCE AND CORRELATION WITH MALARIA TRANSMISSION INTENSITY. Am J Trop Med Hyg, October 1, 2006; 75(4): 582 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wickramarachchi, P. H. Premaratne, K. L. R. L. Perera, S. Bandara, C. H. M. Kocken, A. W. Thomas, S. M. Handunnetti, and P. V. Udagama-Randeniya Natural Human Antibody Responses to Plasmodium vivax Apical Membrane Antigen 1 under Low Transmission and Unstable Malaria Conditions in Sri Lanka Infect. Immun., January 1, 2006; 74(1): 798 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Drakeley, P. H. Corran, P. G. Coleman, J. E. Tongren, S. L. R. McDonald, I. Carneiro, R. Malima, J. Lusingu, A. Manjurano, W. M. M. Nkya, et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure PNAS, April 5, 2005; 102(14): 5108 - 5113. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |